Search
Johnson & Johnson
JNJAdd to Watchlist
228.390USD
-5.860-2.50%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
549.78BMarket Cap
26.14P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Johnson & Johnson is 7.71, ranking 95 out of 157 in the Pharmaceuticals industry. The average price target is 205.00, with a high of 230.00 and a low of 170.00.
Analyst Rating
Based on
27
analysts
Buy
Current Rating
253.769
Target Price
+8.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Johnson & Johnson
JNJ
27
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Johnson & Johnson's expected revenue for the next quarter?
Johnson & Johnson's expected revenue is 24.99B.
What is Johnson & Johnson's price target?
Analysts forecast that Johnson & Johnson's price target is USD 205.00, with the highest forecast at USD 230.00 and the lowest forecast at USD 170.00.
How have Johnson & JohnsonJNJ's recent earnings per share performed?
The market expectation was USD 2.17, while Johnson & JohnsonJNJ's earnings per share (EPS) for the previous quarter was USD 2.12. EPS for the next quarter is expected at USD 2.84.
What is the analyst rating for Johnson & Johnson?
Based on the ratings of Johnson & Johnson's stock from 27 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
